Blockade of caspase cascade overcomes malaria-associated acute respiratory distress syndrome in mice

阻断胱天蛋白酶级联可克服小鼠疟疾相关的急性呼吸窘迫综合征

阅读:6
作者:Michelle K Sercundes #, Luana S Ortolan #, Viviane da Silva Julio, Leonardo M Bella, Thatyane de Castro Quirino, Daniela Debone, Marcela S Carneiro-Ramos, Marcelo A Christoffolete, Joilson O Martins, Maria Regina D'Império Lima, José M Alvarez, Gustavo P Amarante-Mendes, Lígia Antunes Gonçalves, Cla

Abstract

Malaria is an enormous burden on global health that caused 409,000 deaths in 2019. Severe malaria can manifest in the lungs, an illness known as acute respiratory distress syndrome (ARDS). Not much is known about the development of malaria-associated ARDS (MA-ARDS), especially regarding cell death in the lungs. We had previously established a murine model that mimics various human ARDS aspects, such as pulmonary edema, hemorrhages, pleural effusion, and hypoxemia, using DBA/2 mice infected with Plasmodium berghei ANKA. Here, we explored the mechanisms and the involvement of apoptosis in this syndrome. We found that apoptosis contributes to the pathogenesis of MA-ARDS, primarily as facilitators of the alveolar-capillary barrier breakdown. The protection of pulmonary endothelium by inhibiting caspase activation could be a promising therapeutic strategy to prevent the pathogenicity of MA-ARDS. Therefore, intervention in the programmed death cell mechanism could help patients not to develop severe malaria.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。